The store will not work correctly when cookies are disabled.
N-(1-acetyl-4-thia-1,2-diazaspiro[4.6]undec-2-en-3-yl)acetamide
ID: ALA4294494
PubChem CID: 145994051
Max Phase: Preclinical
Molecular Formula: C12H19N3O2S
Molecular Weight: 269.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C2(CCCCCC2)S1
Standard InChI: InChI=1S/C12H19N3O2S/c1-9(16)13-11-14-15(10(2)17)12(18-11)7-5-3-4-6-8-12/h3-8H2,1-2H3,(H,13,14,16)
Standard InChI Key: TXFVZMJOJPIMRY-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
21.0496 -3.2286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0465 -4.0449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4037 -4.5572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4076 -2.7153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6048 -4.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6067 -2.8979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2523 -3.6385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7156 -3.7143 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.3804 -3.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1316 -2.4579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3153 -2.4564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1559 -3.4966 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.7669 -2.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5424 -3.2116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6023 -2.1534 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8381 -1.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1741 -1.0481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0250 -1.8745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
3 5 1 0
4 6 1 0
5 7 1 0
6 7 1 0
1 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 1 1 0
9 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
11 16 1 0
16 17 2 0
16 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.37 | Molecular Weight (Monoisotopic): 269.1198 | AlogP: 2.04 | #Rotatable Bonds: ┄ |
Polar Surface Area: 61.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.69 | CX Basic pKa: ┄ | CX LogP: 1.78 | CX LogD: 1.78 |
Aromatic Rings: ┄ | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: -0.84 |
References
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |